Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals
Author(s) -
Sandrine Urwyler,
Philipp Schüetz,
Fahim Ebrahimi,
Marc Y. Donath,
Mirjam ChristCrain
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-3931
Subject(s) - medicine , endocrinology , body mass index , morning , metabolic syndrome , obesity , hydrocortisone
Increased cortisol levels in obesity may contribute to the associated metabolic syndrome. In obesity, the activated innate immune system leads to increased interleukin (IL)-1β, which is known to stimulate the release of adrenocorticotropin hormone (ACTH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom